Development and characterization of LTA-appended chitosan nanoparticles for mucosal immunization against hepatitis B

References

• Bramwell VW, Perrie Y. 2006. Particulate delivery systems for vaccines: what can we expect. J Pharm Pharmacol. 58:717–728.
   PubMed Web of Science ®Google Scholar
• Calvo P, Remunan-Lopez C, Vila-Jata JL, Alonso MJ. 1997a. Novel hydrophilic chitosan- polyethylene oxide nanoparticles as protein carriers. Appl Polym Sci. 63:125–132.
   Web of Science ®Google Scholar
• Calvo P, Remunan-Lopez C, Vila-Jata JL, Alonso MJ. 1997b. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res. 14:1431–1436.
   PubMed Web of Science ®Google Scholar
• Chang TMS. 1971. Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Common. 44:1531–1536.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhang ZR, Yuan F, Qin X, Wang M, Huang Y. 2008. In vitro and in vivo study of N- trimethyl chitosan nanoparticles for oral protein delivery. Int J Pharm. 349:226–233.
   PubMed Web of Science ®Google Scholar
• Clark MA, Jepson MA, Hirst BH. 2001. Exploiting M cells for drug and vaccine delivery. Adv Drug Del Rev. 50:81–106.
   PubMed Web of Science ®Google Scholar
• Clark MA, Jepson MA, Simmons NL, Booth TA, Hirst BH. 1993. Differential expression of lectin binding sites defines mouse intestinal M cells. J Histochem Cytochem. 41:1679–1687.
   PubMed Web of Science ®Google Scholar
• De Campos A, Sanchez A, Alonso MJ. 2001. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface application to cyclosporine. Int J Pharm. 224:159–168.
   PubMed Web of Science ®Google Scholar
• Elson CO, Ealding W, Lefkowitz JJ. 1984. A lavage technique following repeated measurement of IgA antibody in mouse intestinal secretions. J Immunol Methods. 67:101–108.
   PubMed Web of Science ®Google Scholar
• Ezpeleta I, Irache JM, Stainmesee S, Chabenat C, Gueguen J, Orecchioni AM. 1996. Peparation of lectin – vicilin nanoparticle conjugates using the carbodiimide coupling technique. Int J Pharm. 142:227–233.
   Web of Science ®Google Scholar
• Fernandez-Urrusuno R, Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. 1991. Enhancemt of nasal absorption of insuln by using chitosan nanoparticles. Pharm Res. 16:1576–1581.
   Google Scholar
• Fernandez-Urrusuno R, Romani D, Calvo P, Vila-Jato JL, Alonso MJ. 1999. Development of freeze- dried formulation of insulin- loaded chitosan nanoparticle intended for nasal administration. Pharm Sci. 9:429–436.
   Google Scholar
• Gabor F, Scwarzbauer A, Wirth M. 2002. Lectin mediated drug delivery: binding and uptake of BSA–WGA conjugates using the caco-2 model. Int J Pharm. 237:227–239.
   PubMed Web of Science ®Google Scholar
• Gan Q, Wang T, Cochrane C, McCarron P. 2005. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces. 44:65–73.
   PubMed Web of Science ®Google Scholar
• Gao X, Tao W, Lu W, Zhang Q, Zhang Y, Jiang X, Fu S. 2006. Lectin – conjugated PEG- PLA nanoparticles: Preparation and brain delivery after intranasal administration. Biomaterials. 27:3482–3490.
   PubMed Web of Science ®Google Scholar
• Gupta PN, Khatri K, Goyal AK, Mishra N, Vyas SP. 2007. M cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J Drug Target. 15:701–713.
   PubMed Web of Science ®Google Scholar
• Gupta PN, Mahor S, Rawat A, Khatri K, Goyal A, Vyas SP. 2006. Lectin anchored stabilized biodegradable nanoparticles for oral immunizations: development and in vitro evaluation. Int J Pharm. 318:163–173.
   PubMed Web of Science ®Google Scholar
• He Q, Mitchell A, Morcol T, Bell SJD. 2002. Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2. Clin Diagn Lab Immunol. 9:1021–1024.
   PubMedGoogle Scholar
• Illum L. 1998. Chitosan and its use as a pharmaceutical excipients. Pharm Res. 15:1326–1331.
   PubMed Web of Science ®Google Scholar
• Jaganathan KS, Vyas SP. 2006. Strong systemic and mucosal immune responses to surface- modified PLGA microspheres containing recombinant Hepatitis B antigen administered intranasally. Vaccine. 24:4201–4211.
   PubMed Web of Science ®Google Scholar
• Jain S, Singh P, Mishra V, Vyas SP. 2005. Mannosylated niosomes as adjuvant carrier system for oral genetic immunization against Hepatitis B. Immunol Lett. 101:41–49.
   PubMed Web of Science ®Google Scholar
• Jordan SL, Russo MR, Blessing RL, Theis AB. 1996. Inactivation of glutardehyde. J Toxicol Environ Health. 47:299–309.
   PubMed Web of Science ®Google Scholar
• Khatri K, Goyal AK, Gupta PN, Mishra N, Mehta A, Vyas SP. 2008. Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine. 26:2225–2233.
   PubMed Web of Science ®Google Scholar
• Kilpatric DC, Pusztai A, Grant G, Graham C, Ewen SW. 1985. Tomato lectin resists digestion in the mammalian alimentary canal and binds to intestinal villi without deletious effects. FEBS Lett. 185: 299–305.
   Google Scholar
• Lavelle EC, Grant G, Pfuller U, O’Hagan DT. 2004. Immunological implication of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract. J Drug Target. 12:89–95.
   PubMed Web of Science ®Google Scholar
• Lavelle EC, Grant G, Pusztai A, Fuller U, O’Hagan DT. 2001. Identification of plant lectin with mucosal adjuvant activity. Immunol. 102:77–86.
   PubMed Web of Science ®Google Scholar
• Lehr CM, Bouwstra JA, Kok W, Noach AB, de Boer AG, Junginger HE. 1992. Bioadhesion by means of specific binding of tomato lectin. Pharm Res. 9:547–553.
   PubMed Web of Science ®Google Scholar
• Lis B, Sharon N. 1986. Lectins as molecules and as tools. Annu Rev Biochem. 55:35–67.
   PubMed Web of Science ®Google Scholar
• Mishra N, Goyal AK, Khatri K, Vaidya B, Paliwal R, Rai S, et al. 2008. Biodegradable polymer based particulate carrier(s) for the delivery of proteins and peptides. Antiinflammat AntiAllergy Agents Med Chem. 7:240–251.
   Google Scholar
• Mishra N, Tiwari S, Vaidya B, Agrawal GP, Vyas SP. 2010. Lectin anchored PLGA nanoparticles for oral mucosal immunization against Hepatitis B. J Drug Target. 19:67–78.
   PubMed Web of Science ®Google Scholar
• Monsan P, Puzo G, Mazarguil H. 1975. Étude du mécanisme d’établissement des liaisons glutaraldehyde protéines. Biochimie. 57:1281–1292.
   PubMed Web of Science ®Google Scholar
• Montisci MJ, Dembri A, Giovannuci G, Chacun H, Duchene D, Ponchel G. 2001a. Gastrointestinal transit and mucoadheasion of colloidal suspension of Lycopersicon esculentum L. and Lotus tetragonolobus Lectin- PLA microsphere conjugates in rats. Pharm Res. 18:829–837.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Nishimura S, Nishi N, Saiki I, Tokura S, Azuma I. 1984. Immunological activity of chitin and its derivatives. Vaccine. 2:93–99.
   PubMedGoogle Scholar
• Nugent J, Po AL, Scott EM. 1998. Design and delivery of non-parenteral vaccines. J Clin Pharm Ther. 23:257–285.
   PubMed Web of Science ®Google Scholar
• O’Hagan DT. 1998. Microparticles and polymers for the mucosal delivery of vaccines. Adv Drug Del Rev. 34:305–320.
   PubMed Web of Science ®Google Scholar
• Pereira MEA, Kabat EA. 1974. Specificity of purified hemagglutin in lectin from Lotus tetragonolobus. Biochemistry. 13:3184–3192.
   PubMed Web of Science ®Google Scholar
• Ponchel G, Irache JM. 1998. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Del Rev. 34:191–219.
   PubMed Web of Science ®Google Scholar
• Roth-Watler F, Scholl E, Untersmayr I, Ellinger A, Boltz-Nitulescu G, Scheiner O, et al. 2005. Mucosal targeting of allergen-loaded microspheres by Alenuria auerantia lectin. Vaccine. 23:2703–2710.
   PubMed Web of Science ®Google Scholar
• Roth-Watler F, Scholl I, Untersmayr E, Fuchs R, Boltz-Nitulescu G, Weissenbock A, et al. 2004. M cell targeting with Alenuria auerantia lectin as a novel approach for oral allergen immunotherapy. J Allergy Clin Immunol. 114:1362–1368.
   PubMed Web of Science ®Google Scholar
• Russell-Jones GJ, Veitch H, Arthur L. 1999. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int J Pharm. 190:165–174.
   PubMed Web of Science ®Google Scholar
• Sachdeva S, Ahmad G, Malhotra P, Mukherjee P, Chauhan VS. 2004. Comparison of immunogenicities of recombinant plasmodium vivax merozoite surface protein 119 and 42 kilodalton fragments expressed in Escherichia coli. Infect Immun. 70:5775–5785.
   Web of Science ®Google Scholar
• Shi L, Caulfield MJ, Chern RT, Wilson RA, Sanyal G, Volkin DB. 2002. Pharmaceutical and immunological evaluation of single-shot hepatitis B vaccine formulated with PLGA microspheres. J Pharm Sci. 91:1019–1035.
   PubMed Web of Science ®Google Scholar
• Singh M, Li X, McGhee JP, Zamb T, Koff W, Wang CY, O’Hagan DT. 1997. Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice. Vaccine. 15: 475–481.
   PubMed Web of Science ®Google Scholar
• Singh P, Prabakaran D, Jain S, Mishra V, Jaganathan KS, Vyas SP. 2004. Cholera toxin B sub-unit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int J Pharm. 278:379–390.
   PubMed Web of Science ®Google Scholar
• van der Lubben IM, Kersten G, Fretz MM, Beuvery C, Coos Verhoef J, Junginger HE. 2003. Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine. 21:1400–1408.
   PubMed Web of Science ®Google Scholar
• van der Lubben IM, Konings FA, Borchard G, Verhoef JC, Junginger HE. 2001a. In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry. J Drug Target. 9:39–47.
   PubMed Web of Science ®Google Scholar
• van der Lubben IM, Verhoef JC, Borchard G, Junginger HE. 2001b. Chitosan for mucosal vaccination. Adv Drug Del Rev. 52:139–144.
   PubMed Web of Science ®Google Scholar
• van der Lubben IM, Verhoef JC, van Aelst AC, Borchard G, Junginger HE. 2001c. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials. 22:687–694.
   PubMed Web of Science ®Google Scholar
• Vyas SP, Sihorkar V, Dubey PK. 2001. Preparation, characterization and in-vitro antimicrobial activity of metronidazole bearing lectinized liposomes for intra peridontal pocket delivery. Pharmazie. 56:554–560.
   PubMed Web of Science ®Google Scholar
• Walter F, Scholl I, Untersmayr E, Ellinger A, Boltz-nitulescu G, Scheiner Q, et al. 2004. Functionalization of allergen loaded microspheres with wheat germ agglutinin for targeting enterocytes. Biochem Biophys Res Comm. 315:281–287.
   PubMed Web of Science ®Google Scholar
• Xu Y, Du Y. 2003. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm. 250: 215–226.
   PubMed Web of Science ®Google Scholar